ArticleToxicology and applied pharmacology2013

Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.

Deepali Kurundkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.